0000313616-23-000004.txt : 20230118 0000313616-23-000004.hdr.sgml : 20230118 20230118170826 ACCESSION NUMBER: 0000313616-23-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230118 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230118 DATE AS OF CHANGE: 20230118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 23535088 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 8-K 1 dhr-20230118.htm 8-K dhr-20230118
false000031361600003136162023-01-182023-01-180000313616us-gaap:CommonStockMember2023-01-182023-01-180000313616us-gaap:SeriesBPreferredStockMember2023-01-182023-01-180000313616dhr:A17SeniorNotesDue2024Member2023-01-182023-01-180000313616dhr:A0.2SeniorNotesDue2026Member2023-01-182023-01-180000313616dhr:A21SeniorNotesDue2026Member2023-01-182023-01-180000313616dhr:A1.2SeniorNotesDue2027Member2023-01-182023-01-180000313616dhr:A0.45SeniorNotesDue2028Member2023-01-182023-01-180000313616dhr:A25SeniorNotesDue2030Member2023-01-182023-01-180000313616dhr:A0.75SeniorNotesDue2031Member2023-01-182023-01-180000313616dhr:A1.35SeniorNotesDue2039Member2023-01-182023-01-180000313616dhr:A1.8SeniorNotesDue2049Member2023-01-182023-01-18

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): January 18, 2023
__________________
dhr-20230118_g1.jpg
DANAHER CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
__________________
Delaware001-0808959-1995548
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
2200 Pennsylvania Avenue, NW20037-1701
Suite 800W
Washington,DC
(Address of Principal Executive Offices) (Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.01 par valueDHRNew York Stock Exchange
5.00% Mandatory Convertible Preferred Stock, Series B, without par valueDHR.PRBNew York Stock Exchange
1.700% Senior Notes due 2024DHR 24New York Stock Exchange
0.200% Senior Notes due 2026DHR/26New York Stock Exchange
2.100% Senior Notes due 2026DHR 26New York Stock Exchange
1.200% Senior Notes due 2027DHR/27New York Stock Exchange
0.450% Senior Notes due 2028DHR/28New York Stock Exchange
2.500% Senior Notes due 2030DHR 30New York Stock Exchange
0.750% Senior Notes due 2031DHR/31New York Stock Exchange
1.350% Senior Notes due 2039DHR/39New York Stock Exchange
1.800% Senior Notes due 2049DHR/49New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 


ITEM 7.01
REGULATION FD DISCLOSURE
During the fourth quarter of 2022, changes in Danaher Corporation’s (“Danaher” or the “Company”) internal organization resulting from the rate of growth within certain of the Company’s businesses in the former Life Sciences segment resulted in changes in the composition of the Company’s reportable segments. On January 18, 2023, the Company made available in the Investor Relations section of www.danaher.com, under the heading “Financial Reports”, unaudited historical financial data that has been recast to reflect the four business segments that constitute the Company’s new segment reporting structure: Biotechnology; Life Sciences; Diagnostics; and Environmental & Applied Solutions. The Company previously reported its operations under three business segments: Life Sciences; Diagnostics; and Environmental & Applied Solutions. The Company’s Annual Report on Form 10-K for the year ended December 31, 2022 will also reflect this new segment reporting structure.
The change in segment reporting will be reflected retrospectively, but in no way revises or restates any Consolidated Statements of Earnings, Consolidated Balance Sheets, Consolidated Statements of Shareholders’ Equity or Consolidated Statements of Cash Flows for the Company for any period previously filed with the U.S. Securities and Exchange Commission.
Below are descriptions of the two new segments, Biotechnology and Life Sciences, which together previously constituted the former Life Sciences segment.
Biotechnology
The Biotechnology segment includes the Company’s bioprocessing and discovery and medical businesses.
Bioprocessing — The bioprocessing business is a leading provider of technologies, consumables, services and solutions that advance, accelerate and integrate the development and manufacture of therapeutics. These therapeutics include protein-based and other biological therapies as well as a new emerging class of highly-targeted therapies such as cell and gene therapies, nucleic acid-based therapies, and others requiring viral vectors and lipid nanoparticles in their manufacture. The business offers tools, solutions and services to support biomanufacturers across their workflows from the earliest stages of process development to large scale commercial and turn-key manufacturing. The bioprocessing business’ offering includes cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish, as well as single-use hardware and consumables and services such as the design and installation of full manufacturing suites. The bioprocessing business’ offering in data connectivity and automation, advanced process training, process development services and equipment services for maintaining continuous performance, all help to ensure customers’ processes are optimized and compliant. Typical users of these products and services include pharmaceutical and biopharmaceutical companies, translational medicine institutions, biotechnology companies and contract manufacturing organizations.
Discovery and Medical — The discovery and medical business is a leading provider of solutions to accelerate biotherapeutic research and discovery through high quality sample preparation, and reliable diagnostic assays in addition to ensuring sterility and safety in medical liquids and gasses. The business provides solutions and technologies for: lab filtration, separation, and purification; lab-scale protein purification and analytical tools to support bio-molecular analysis, identification, and characterization; reagents, membranes and services for diagnostic and assay development; and healthcare filtration solutions for drug delivery and patient care that help minimize patient risk from viral infections in clinical settings. Typical users of these products include professionals in the areas of academic, translational and commercial research, medical diagnostics, clinical care and biopharmaceutical development.
The businesses in Danaher’s Biotechnology segment market their products and services under several key brands including CYTIVA and PALL.
Life Sciences
The Life Sciences segment consists of the following businesses:
Flow Cytometry, Genomics, Lab Automation, Centrifugation, Particle Counting and Characterization—The business offers workflow instruments and consumables that help researchers analyze genomic, protein and cellular information. Key product areas include sample preparation equipment such as centrifugation and consumables; liquid handling automation instruments and associated consumables; flow cytometry instrumentation and associated antibodies and reagents; particle counting and characterization instrumentation; and genomic sample preparation. Researchers use these products to study biological function in the pursuit of basic research, as well as therapeutic and diagnostic development. Typical users include pharmaceutical and biotechnology companies, universities, medical schools and research institutions and in some cases industrial manufacturers.


Mass Spectrometry—The mass spectrometry business is a leading global provider of high-end mass spectrometers as well as related consumables, software and services. Mass spectrometry is a technique for identifying, analyzing and quantifying elements, chemical compounds and biological molecules, individually or in complex mixtures. The mass spectrometers utilize various combinations of quadrupole, time-of-flight and ion trap technologies. The business’ mass spectrometer systems and related products are used in numerous applications such as drug discovery and clinical development of therapeutics as well as in basic research, clinical testing, food and beverage quality testing and environmental testing. The business’ global services network provides implementation, validation, training and maintenance to support customer installations around the world. Typical users of these mass spectrometry and related products include molecular biologists, bioanalytical chemists, toxicologists and forensic scientists as well as quality assurance and quality control technicians. The business also provides high-performance bioanalytical measurement systems, including capillary electrophoresis instruments, associated reagents, software and services. Typical users of these capillary electrophoresis instruments and related products are bioanalytical chemists and quality control technicians engaged in the development and manufacture of new biotherapeutics.
Microscopy—The microscopy business is a leading global provider of professional microscopes designed to capture, manipulate and preserve images and enhance the user’s visualization and analysis of microscopic structures. The Company’s microscopy products include laser scanning (confocal) microscopes, compound microscopes and related equipment, surgical and other stereo microscopes and specimen preparation products for electron microscopy. Typical users of these products include research, medical and surgical professionals operating in research and pathology laboratories, academic settings and surgical theaters.
Industrial Filtration—The filtration, separation and purification technologies business is a leading provider of products used to remove solid, liquid and gaseous contaminants from a variety of liquids and gases in industrial settings, primarily through the sale of filtration consumables and to a lesser extent systems that incorporate filtration consumables and associated hardware. The business’ core materials and technologies can be applied in many ways to solve complex fluid separation challenges, and are sold across a wide array of applications. Virtually all of the raw materials, process fluids and waste streams that are found in industry are candidates for multiple stages of filtration, separation and purification. In addition, most of the machines used in complex production processes require filtration to protect sensitive parts from degradation due to contamination. The business’ technologies enhance the quality and efficiency of manufacturing processes and prolong equipment life in applications such as microelectronics, aircraft, oil refineries, power generation turbines, petrochemical plants and food and beverage plants. Within these segments, demand is driven by end-users and original equipment manufacturers seeking to improve product performance, increase production and efficiency, reduce operating costs, extend the life of their equipment, conserve water and meet environmental regulations. The business also serves the filtration needs of the food and beverage markets, helping customers ensure the quality and safety of their products while lowering operating costs and minimizing waste.
Genomic Consumables—The genomic consumables businesses are leading providers of custom nucleic acid products for the life sciences industry, primarily through the manufacture of custom DNA and RNA oligonucleotides and gene fragments utilizing a proprietary manufacturing ecosystem. The businesses have developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, qPCR, and RNA interference. Additionally, the businesses are a leading manufacturer of high-quality plasmid DNA, RNA and proteins. These products are used in the research, development and manufacture of gene and cell therapies, DNA and RNA vaccines and gene editing technologies. Typical users of these products include professionals in the areas of academic and commercial research, agriculture, medical diagnostics, pharmaceutical development, biotechnology companies and research institutions across discovery, clinical and commercial applications.
The businesses in Danaher’s Life Sciences segment market their products and services under key brands including ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX.
The Diagnostics and Environmental & Applied Solutions businesses remain unchanged from the discussion in the Company’s Annual Report on Form 10-K for the year ending December 31, 2021.
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.



ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c)Exhibits:
Exhibit No.  Description
104Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DANAHER CORPORATION
Date:January 18, 2023By:/s/ Matthew R. McGrew
Matthew R. McGrew
Executive Vice President and Chief Financial Officer


 EX-101.SCH 2 dhr-20230118.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover page Cover page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 dhr-20230118_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 4 dhr-20230118_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Floating Rate Senior Notes Due 2022 Floating Rate Senior Notes Due 2022 [Member] Floating Rate Senior Notes Due 2022 Member [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer 1.2% Senior Notes Due 2027 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code 2.1% Senior Notes due 2026 2.1% Senior Notes due 2026 [Member] 2.1% Senior Notes due 2026 0.2% Senior Notes Due 2026 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] Document Period End Date Document Period End Date 0.45% Senior Notes Due 2028 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] Entity Central Index Key Entity Central Index Key Entity Emerging Growth Company Entity Emerging Growth Company Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One 2.5% Senior Notes due 2030 2.5% Senior Notes due 2030 [Member] 2.5% Senior Notes due 2030 Common stock Common Stock [Member] Entity Address, Address Line Two Entity Address, Address Line Two Entity Registrant Name Entity Registrant Name Written Communications Written Communications Local Phone Number Local Phone Number Soliciting Material Soliciting Material Entity Address, State or Province Entity Address, State or Province City Area Code City Area Code Document Type Document Type Class of Stock [Domain] Class of Stock [Domain] Cover [Abstract] Cover [Abstract] Entity Address, City or Town Entity Address, City or Town Class of Stock [Axis] Class of Stock [Axis] Pre-commencement Tender Offer Pre-commencement Tender Offer Entity File Number Entity File Number Entity Listings [Line Items] Entity Listings [Line Items] 1.35% Senior Notes Due 2039 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] 1.7% Senior Notes Due 2024 1.7% Senior Notes Due 2024 [Member] 1.7% Senior Notes Due 2024 Amendment Flag Amendment Flag Entity Listings [Table] Entity Listings [Table] Trading Symbol Trading Symbol Series B Preferred Stock Series B Preferred Stock [Member] Entity Tax Identification Number Entity Tax Identification Number 1.8% Senior Notes Due 2049 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] 0.75% Senior Notes Due 2031 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] EX-101.PRE 5 dhr-20230118_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 6 dhr-20230118_g1.jpg begin 644 dhr-20230118_g1.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover page Cover page
Jan. 18, 2023
Entity Listings [Line Items]  
Document Type 8-K
Document Period End Date Jan. 18, 2023
Entity Registrant Name DANAHER CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-08089
Entity Tax Identification Number 59-1995548
Entity Address, Address Line One 2200 Pennsylvania Avenue, NW
Entity Address, Address Line Two Suite 800W
Entity Address, City or Town Washington,
Entity Address, State or Province DC
Entity Address, Postal Zip Code 20037-1701
City Area Code 202
Local Phone Number 828-0850
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0000313616
Common stock  
Entity Listings [Line Items]  
Title of 12(b) Security Common stock, $0.01 par value
Trading Symbol DHR
Security Exchange Name NYSE
Series B Preferred Stock  
Entity Listings [Line Items]  
Title of 12(b) Security 5.00% Mandatory Convertible Preferred Stock, Series B, without par value
Trading Symbol DHR.PRB
Security Exchange Name NYSE
1.7% Senior Notes Due 2024  
Entity Listings [Line Items]  
Title of 12(b) Security 1.700% Senior Notes due 2024
Trading Symbol DHR 24
Security Exchange Name NYSE
0.2% Senior Notes Due 2026  
Entity Listings [Line Items]  
Title of 12(b) Security 0.200% Senior Notes due 2026
Trading Symbol DHR/26
Security Exchange Name NYSE
2.1% Senior Notes due 2026  
Entity Listings [Line Items]  
Title of 12(b) Security 2.100% Senior Notes due 2026
Trading Symbol DHR 26
Security Exchange Name NYSE
1.2% Senior Notes Due 2027  
Entity Listings [Line Items]  
Title of 12(b) Security 1.200% Senior Notes due 2027
Trading Symbol DHR/27
Security Exchange Name NYSE
0.45% Senior Notes Due 2028  
Entity Listings [Line Items]  
Title of 12(b) Security 0.450% Senior Notes due 2028
Trading Symbol DHR/28
Security Exchange Name NYSE
2.5% Senior Notes due 2030  
Entity Listings [Line Items]  
Title of 12(b) Security 2.500% Senior Notes due 2030
Trading Symbol DHR 30
Security Exchange Name NYSE
0.75% Senior Notes Due 2031  
Entity Listings [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2031
Trading Symbol DHR/31
Security Exchange Name NYSE
1.35% Senior Notes Due 2039  
Entity Listings [Line Items]  
Title of 12(b) Security 1.350% Senior Notes due 2039
Trading Symbol DHR/39
Security Exchange Name NYSE
1.8% Senior Notes Due 2049  
Entity Listings [Line Items]  
Title of 12(b) Security 1.800% Senior Notes due 2049
Trading Symbol DHR/49
Security Exchange Name NYSE
XML 8 dhr-20230118_htm.xml IDEA: XBRL DOCUMENT 0000313616 2023-01-18 2023-01-18 0000313616 us-gaap:CommonStockMember 2023-01-18 2023-01-18 0000313616 us-gaap:SeriesBPreferredStockMember 2023-01-18 2023-01-18 0000313616 dhr:A17SeniorNotesDue2024Member 2023-01-18 2023-01-18 0000313616 dhr:A0.2SeniorNotesDue2026Member 2023-01-18 2023-01-18 0000313616 dhr:A21SeniorNotesDue2026Member 2023-01-18 2023-01-18 0000313616 dhr:A1.2SeniorNotesDue2027Member 2023-01-18 2023-01-18 0000313616 dhr:A0.45SeniorNotesDue2028Member 2023-01-18 2023-01-18 0000313616 dhr:A25SeniorNotesDue2030Member 2023-01-18 2023-01-18 0000313616 dhr:A0.75SeniorNotesDue2031Member 2023-01-18 2023-01-18 0000313616 dhr:A1.35SeniorNotesDue2039Member 2023-01-18 2023-01-18 0000313616 dhr:A1.8SeniorNotesDue2049Member 2023-01-18 2023-01-18 false 0000313616 8-K 2023-01-18 DANAHER CORPORATION DE 001-08089 59-1995548 2200 Pennsylvania Avenue, NW 20037-1701 Suite 800W Washington, DC 202 828-0850 false false false false Common stock, $0.01 par value DHR NYSE 5.00% Mandatory Convertible Preferred Stock, Series B, without par value DHR.PRB NYSE 1.700% Senior Notes due 2024 DHR 24 NYSE 0.200% Senior Notes due 2026 DHR/26 NYSE 2.100% Senior Notes due 2026 DHR 26 NYSE 1.200% Senior Notes due 2027 DHR/27 NYSE 0.450% Senior Notes due 2028 DHR/28 NYSE 2.500% Senior Notes due 2030 DHR 30 NYSE 0.750% Senior Notes due 2031 DHR/31 NYSE 1.350% Senior Notes due 2039 DHR/39 NYSE 1.800% Senior Notes due 2049 DHR/49 NYSE false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 12 23 1 false 11 0 false 0 false false R1.htm 0000001 - Document - Cover page Cover page Sheet http://www.danaher.com/role/CoverpageCoverpage Cover page Cover page Cover 1 false false All Reports Book All Reports dhr-20230118.htm dhr-20230118.xsd dhr-20230118_def.xml dhr-20230118_lab.xml dhr-20230118_pre.xml dhr-20230118_g1.jpg http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dhr-20230118.htm": { "axisCustom": 0, "axisStandard": 1, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2021q4": 53 }, "contextCount": 12, "dts": { "definitionLink": { "local": [ "dhr-20230118_def.xml" ] }, "inline": { "local": [ "dhr-20230118.htm" ] }, "labelLink": { "local": [ "dhr-20230118_lab.xml" ] }, "presentationLink": { "local": [ "dhr-20230118_pre.xml" ] }, "schema": { "local": [ "dhr-20230118.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 40, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 9, "memberStandard": 2, "nsprefix": "dhr", "nsuri": "http://www.danaher.com/20230118", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhr-20230118.htm", "contextRef": "i320169c87b9a4c38b71d5d336dcdcc4f_D20230118-20230118", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Cover page Cover page", "menuCat": "Cover", "order": "1", "role": "http://www.danaher.com/role/CoverpageCoverpage", "shortName": "Cover page Cover page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhr-20230118.htm", "contextRef": "i320169c87b9a4c38b71d5d336dcdcc4f_D20230118-20230118", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 11, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]", "terseLabel": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]", "terseLabel": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "booleanItemType" }, "dhr_A0.2SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.2% Senior Notes Due 2026 [Member]", "label": "0.2% Senior Notes Due 2026 [Member]", "terseLabel": "0.2% Senior Notes Due 2026" } } }, "localname": "A0.2SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A0.45SeniorNotesDue2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.45% Senior Notes Due 2028 [Member]", "label": "0.45% Senior Notes Due 2028 [Member]", "terseLabel": "0.45% Senior Notes Due 2028" } } }, "localname": "A0.45SeniorNotesDue2028Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A0.75SeniorNotesDue2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "0.75% Senior Notes Due 2031 [Member]", "label": "0.75% Senior Notes Due 2031 [Member]", "terseLabel": "0.75% Senior Notes Due 2031" } } }, "localname": "A0.75SeniorNotesDue2031Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A1.2SeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.2% Senior Notes Due 2027 [Member]", "label": "1.2% Senior Notes Due 2027 [Member]", "terseLabel": "1.2% Senior Notes Due 2027" } } }, "localname": "A1.2SeniorNotesDue2027Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A1.35SeniorNotesDue2039Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.35% Senior Notes Due 2039 [Member]", "label": "1.35% Senior Notes Due 2039 [Member]", "terseLabel": "1.35% Senior Notes Due 2039" } } }, "localname": "A1.35SeniorNotesDue2039Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A1.8SeniorNotesDue2049Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.8% Senior Notes Due 2049 [Member]", "label": "1.8% Senior Notes Due 2049 [Member]", "terseLabel": "1.8% Senior Notes Due 2049" } } }, "localname": "A1.8SeniorNotesDue2049Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A17SeniorNotesDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1.7% Senior Notes Due 2024", "label": "1.7% Senior Notes Due 2024 [Member]", "terseLabel": "1.7% Senior Notes Due 2024" } } }, "localname": "A17SeniorNotesDue2024Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A21SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.1% Senior Notes due 2026", "label": "2.1% Senior Notes due 2026 [Member]", "terseLabel": "2.1% Senior Notes due 2026" } } }, "localname": "A21SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_A25SeniorNotesDue2030Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2.5% Senior Notes due 2030", "label": "2.5% Senior Notes due 2030 [Member]", "terseLabel": "2.5% Senior Notes due 2030" } } }, "localname": "A25SeniorNotesDue2030Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "dhr_FloatingRateSeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Floating Rate Senior Notes Due 2022 Member [Member]", "label": "Floating Rate Senior Notes Due 2022 [Member]", "terseLabel": "Floating Rate Senior Notes Due 2022" } } }, "localname": "FloatingRateSeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20230118", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.danaher.com/role/CoverpageCoverpage" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 15 0000313616-23-000004-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313616-23-000004-xbrl.zip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